Baird Financial Group’s Catheter Precision VTAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-529
Closed -$58.8K 1835
2024
Q2
$58.8K Hold
529
﹤0.01% 1731
2024
Q1
$48.9K Hold
529
﹤0.01% 1734
2023
Q4
$40.7K Hold
529
﹤0.01% 1693
2023
Q3
$44.7K Hold
529
﹤0.01% 1688
2023
Q2
$92.5K Buy
+529
New +$122K ﹤0.01% 1656

Other funds holding VTAK

Baird Financial Group's VTAK Position: Q3 2024 in Review

Baird Financial Group sold out of Catheter Precision (VTAK) in Q3 2024, closing a stake of 529 shares — an estimated $58.8K sold.

Baird Financial Group first reported a position in VTAK in Q2 2023 and held it in 5 quarters. The position peaked at $92.5K in Q2 2023. 9 funds tracked by Wall St. Rank hold VTAK as of Q3 2024.

  • Baird Financial Group reported no remaining Catheter Precision position as of Q3 2024 after selling out during the quarter.
  • Baird Financial Group sold 529 Catheter Precision shares in Q3 2024, an estimated $58.8K.
  • Baird Financial Group first reported a position in Catheter Precision in Q2 2023 and held it in 5 quarters.
  • Baird Financial Group's Catheter Precision position peaked at $92.5K in Q2 2023.
  • 9 funds tracked by Wall St. Rank held Catheter Precision as of Q3 2024.

Based on Baird Financial Group's 13F filing for Q3 2024, filed 14 Nov 2024.